United Therapeutics Corporation (UTHR) scores 69 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 533.71, representing a 6% premium to fair value. Quantitative score: 66/100. Qualitative score: 80/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.